18
Views
3
CrossRef citations to date
0
Altmetric
Research Article

Soluble P-selectin is influenced by cancer chemotherapy

, , , &
Pages 37-38 | Published online: 07 Jul 2009

  • Stenberg P E, McEver R P, Schuman M A, Jaques Y V, Bainton D F. A platelet alpha granule membrane protein (GMP-140) is expressed on the plasma membrane after activation. J Cell Biol 1985; 101: 880-6.
  • Blann A D, Dobrotova M, Kubisz, McCollum C N. von Willebrand Factor, soluble P-selectin, tissue plasminogen activator and plasminogen activator inhibitor in atherosclerosis. Thromb Haemost 1995; 74: 626-30.
  • Katayama M, Handa M, Araki Y, Ambo H, Kawai Y, Watanabe K, Ikeda Y. Soluble P-selectin is present in normal circulation and its plasma level is elevated in patients with thrombotic thrombocytopenic purpura and haemolytic uraemic syndrome. Br J Haematol 1993; 84: 702-10.
  • Takeda I, Kaise S, Nishimaki T, Kasukawa R. Soluble P-selectin in the plasma of patients with connective tissue disorders. Int Arch Immunol 1994; 105: 128-34.
  • Jilma B, Fasching P, Ruthner C, Rumplmayr A, Ruzicka S, Kapiotis S, Wagner O F, Eichler H G. Elevated circulating P-selectin in insulin dependant diabetes mellitus. Thromb Haemost 1996; 76: 328-32.
  • Blann A D, Lip G Y H. Hypothesis: is soluble P-selectin a new marker of platelet activation? Atherosclerosis 1997; 128: 13S-8.
  • Fijnheer R, Frijns C JM, Korteweg J, Rommes H, Peters J H, Sixma J J, Nieuwenhuis H K. The origin of P-selectin as a circulating plasma protein. Thromb Haemost 1997; 77: 1081-5.
  • Kawabata K, Nagake Y, Shikata K, Fukuda S, Nakazono H, TakahashiM, Ichikawa H, Makino H. Soluble P-selectin is released from activated platelets m vivo during haemodialysis. Nephron 1998; 78: 148-55.
  • Smith A, Quarmby J W, Collins M, Locjhart SM, Burnand K G. Changes in the levels of solunle adhesion molecules and coagulation factors in patients with deep vein thrombosis. Thromb Haemost 1999; 82: 1593-9.
  • Ferroni P, Pulcinelli FM, Lenti L, Gazzaniga P P. Is soluble P selectin determination a more reliable marker of in vivo platelet activation than CD62P flow cytometric analysis. Thromb Haemost 1999; 81: 472-3.
  • Gurney D, Wadley M, Stonelake P, Bereford D, Lip G Y H, Blann A D. Increased levels of soluble P selectin, a marker of platelet activation, in solid and haematological cancer. Blood Coag Fibrinol 1999; 10: P15 (Abstr) (Full paper in press, Blood Coag Fibrinol 2001).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.